ImpediMed Limited

ASX:IPD.AX

0.053 (AUD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q42008 Q32008 Q22008 Q12007 Q42007 Q32007 Q2
Revenue 5.5354.7845.6895.6555.375.1964.833.5792.9042.8372.3261.8011.8011.5172.8922.8743.082.7112.762.0841.911.6111.471.26300.7360.7360.97200.9720.9720.9100.910.910.74800.7480.7480.58500.5850.5850000
Cost of Revenue 0.68212.61312.10212.72412.61211.14310.45110.169.5339.0969.0710.670.5460.430.7280.7610.8710.7120.7320.5920.5220.4460.6610.51300.3160.3160.41400.4140.4140.40200.4020.4020.35700.3570.3570.17300.1730.1730000
Gross Profit 4.853-7.829-6.413-7.069-7.242-5.947-5.621-6.581-6.629-6.259-6.7451.1311.2551.0872.1642.1132.2091.9992.0281.4921.3881.1650.8090.7500.420.420.55800.5580.5580.50800.5080.5080.39100.3910.3910.41200.4120.4120000
Gross Profit Ratio 0.877-1.636-1.127-1.25-1.349-1.145-1.164-1.839-2.283-2.206-2.90.6280.6970.7170.7480.7350.7170.7370.7350.7160.7270.7230.550.59400.570.570.57400.5740.5740.55800.5580.5580.52300.5230.5230.70400.7040.7040000
Reseach & Development Expenses 1.7670.1250.1110.4870.4320.2510.6370.8191.3341.9741.5041.4541.3061.6582.1453.1912.6761.3650.7690.2660.2080.1930.0960.45800.6960.6960.34500.3450.3450.31600.3160.3160.73200.7320.7320.45700.4570.4570000
General & Administrative Expenses 2.8993.3582.4752.852.6232.2272.4972.3681.9012.70702.1283.2613.7323.1592.9485.0392.6891.8221.7031.7051.3311.5861.53301.9041.9042.84202.8422.8422.00202.0022.0021.61901.6191.6191.16801.1681.1680000
Selling & Marketing Expenses 0.5240.7730.2410.2170.3540.3150.2870.160.8753.33309.5250.6170.2020.6070.5880.930.3650.7390.5570.280.1970.1670.28700.1940.1940.12500.1250.1250.04100.0410.0410.16200.1620.1620.10100.1010.1010000
SG&A 11.7354.1313.9484.2823.7543.3454.7974.5373.0836.045.01611.65314.61715.05615.21314.25316.69511.78710.057.4325.6814.3755.25702.0992.0992.96702.9672.9672.04302.0432.0431.7801.781.781.26901.2691.2690000
Other Expenses -19.1810000000000000000000000-1.6450-1.946-1.946-2.4190-2.419-2.419-1.4720-1.472-1.472-1.2970-1.297-1.297-0.7410-0.741-0.7410000
Operating Expenses -5.6794.2564.0594.7694.1863.5965.4345.3564.4178.0146.5213.48914.26715.70916.0916.08517.10613.23810.767.645.764.7854.1736.04200.8490.8490.89300.8930.8930.88700.8870.8871.21501.2151.2150.98500.9850.9850000
Operating Income 10.532-12.085-10.472-11.838-11.428-9.543-11.055-11.937-11.046-14.273-13.265-13.729-14.909-15.803-15.327-15.453-17.261-11.238-8.867-6.278-4.391-3.62-4.155-5.2920-3.34-3.34-3.7950-3.795-3.795-2.9050-2.905-2.905-3.5410-3.541-3.541-2.4520-2.452-2.4520000
Operating Income Ratio 1.903-2.526-1.841-2.093-2.128-1.837-2.289-3.335-3.804-5.031-5.703-7.623-8.278-10.417-5.3-5.377-5.604-4.145-3.213-3.012-2.299-2.247-2.827-4.190-4.536-4.536-3.9050-3.905-3.905-3.1930-3.193-3.193-4.7340-4.734-4.734-4.1890-4.189-4.1890000
Total Other Income Expenses Net -20.5911.8490.27-0.036-0.306-0.17-0.0130.550.369-0.1520.1831.5912.1211.2091.5891.662.496-0.0620.1920.1560.0420.0340.8560.12700.2540.2540.08900.0890.0890.05500.0550.0550.03400.0340.0340.01400.0140.0140000
Income Before Tax -10.059-10.236-10.202-11.874-11.734-9.713-11.068-11.387-9.51-14.425-13.082-12.138-12.788-14.418-13.738-13.793-14.765-11.215-8.675-6.122-4.349-3.586-3.299-5.1650-3.086-3.086-3.7060-3.706-3.706-2.8510-2.851-2.851-3.5070-3.507-3.507-2.4390-2.439-2.4390000
Income Before Tax Ratio -1.817-2.14-1.793-2.1-2.185-1.869-2.292-3.182-3.275-5.085-5.624-6.74-7.1-9.504-4.75-4.799-4.794-4.137-3.143-2.938-2.277-2.226-2.244-4.0890-4.191-4.191-3.8130-3.813-3.813-3.1330-3.133-3.133-4.6880-4.688-4.688-4.1660-4.166-4.1660000
Income Tax Expense 0.013-0.518-0.496-1.059-0.78-0.793-0.8-0.949-1.074-1.484-1.230.0060.0270.0150.04000000000.24600.2540.2540.09200.0920.0920.05500.0550.0550.03600.0360.0360.43600.4360.4360000
Net Income -10.072-9.718-9.706-10.815-10.954-8.92-10.268-10.438-8.436-12.941-11.852-12.144-12.815-14.433-13.778-13.793-14.765-11.215-8.675-6.122-4.349-3.586-3.299-5.1650-3.086-3.086-3.7060-3.706-3.706-2.8510-2.851-2.851-3.5070-3.507-3.507-2.4390-2.439-2.4390000
Net Income Ratio -1.82-2.031-1.706-1.912-2.04-1.717-2.126-2.916-2.905-4.562-5.095-6.743-7.115-9.514-4.764-4.799-4.794-4.137-3.143-2.938-2.277-2.226-2.244-4.0890-4.191-4.191-3.8130-3.813-3.813-3.1330-3.133-3.133-4.6880-4.688-4.688-4.1660-4.166-4.1660000
EPS -0.005-0.005-0.005-0.006-0.006-0.006-0.007-0.01-0.01-0.025-0.03-0.032-0.034-0.038-0.037-0.037-0.043-0.038-0.03-0.025-0.021-0.02-0.017-0.030-0.018-0.018-0.0240-0.024-0.024-0.0230-0.023-0.023-0.0360-0.036-0.036-0.0340-0.034-0.0340000
EPS Diluted -0.005-0.005-0.005-0.006-0.006-0.006-0.007-0.01-0.01-0.025-0.03-0.032-0.034-0.038-0.037-0.037-0.043-0.038-0.03-0.025-0.021-0.02-0.017-0.030-0.018-0.018-0.0240-0.024-0.024-0.0230-0.023-0.023-0.0360-0.036-0.036-0.0340-0.034-0.0340000
EBITDA -11.703-11.753-9.164-11.058-10.057-8.593-10.189-10.514-8.684-13.818-12.695-13.43-14.261-15.259-14.997-15.141-17.159-11.145-8.778-6.192-4.309-3.526-4.074-5.1650-2.969-2.969-3.5550-3.555-3.555-2.6840-2.684-2.684-3.3120-3.312-3.312-1.9280-1.928-1.9280000
EBITDA Ratio -2.114-2.283-1.611-1.888-1.818-1.624-2.111-3.1-3.532-4.803-5.537-7.457-8.172-10.303-5.252-5.334-5.571-4.111-3.18-2.971-2.256-2.189-2.771-4.0890-4.032-4.032-3.6580-3.658-3.658-2.950-2.95-2.95-4.4290-4.429-4.429-3.2930-3.293-3.2930000